Delayed Hypersensitivity Reaction and Acute Respiratory Distress Syndrome Following Infliximab Infusion
Open Access
- 1 May 2002
- journal article
- case report
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 8 (3) , 186-191
Abstract
Summary. Infliximab, a chimeric human/murine monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor alpha, is an effective theKeywords
This publication has 18 references indexed in Scilit:
- Invasive Pulmonary Aspergillosis Associated with Infliximab TherapyNew England Journal of Medicine, 2001
- Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patientsAmerican Journal of Gastroenterology, 2001
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Review article: safety of infliximab in clinical trialsAlimentary Pharmacology & Therapeutics, 1999
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Eosinophilic Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 1994
- The American-European Consensus Conference On Ards. Definitions, Mechanisms, Relevant Outcomes, And Clinical Trial CoordinationAmerican Journal of Respiratory and Critical Care Medicine, 1994
- An Expanded Definition of the Adult Respiratory Distress SyndromeAmerican Review of Respiratory Disease, 1988